Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

Supriya Lifescience Limited (SUPRIYA.NS)

Compare
628.20
+8.40
+(1.36%)
At close: March 6 at 3:30:01 PM GMT+5:30
Advanced Chart
Loading Chart for SUPRIYA.NS
  • Previous Close 619.80
  • Open 629.00
  • Bid --
  • Ask --
  • Day's Range 623.70 - 649.25
  • 52 Week Range 305.50 - 835.20
  • Volume 386,213
  • Avg. Volume 299,217
  • Market Cap (intraday) 50.563B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 29.04
  • EPS (TTM) 21.63
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (0.13%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 740.00

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

448

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Supriya Lifescience Limited

Recent News: SUPRIYA.NS

View More
View More

Performance Overview: SUPRIYA.NS

Trailing total returns as of 3/6/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX .

YTD Return

SUPRIYA.NS
15.09%
S&P BSE SENSEX
4.86%

1-Year Return

SUPRIYA.NS
78.24%
S&P BSE SENSEX
0.34%

3-Year Return

SUPRIYA.NS
51.28%
S&P BSE SENSEX
36.82%

5-Year Return

SUPRIYA.NS
49.22%
S&P BSE SENSEX
97.84%

Compare To: SUPRIYA.NS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

SUPRIYA.NS
Supriya Lifescience Limited
628.20
+1.36%
Mkt Cap INR 50.563B
Industry Biotechnology
ONESOURCE.BO
OneSource Specialty Pharma Limited
1,443.50
+0.27%
Mkt Cap INR 165.188B
Industry Biotechnology
PANACEABIO.NS
Panacea Biotec Limited
359.10
+3.74%
Mkt Cap INR 21.995B
Industry Biotechnology
BIOCON.NS
Biocon Limited
333.00
+2.51%
Mkt Cap INR 398.907B
Industry Biotechnology
CYBN.NE
Cybin Inc.
10.72
-5.22%
Mkt Cap CAD 235.169M
Industry Biotechnology
CYBN
Cybin Inc.
7.46
-4.48%
Mkt Cap 163.514M
Industry Biotechnology
CORT
Corcept Therapeutics Incorporated
54.30
-2.14%
Mkt Cap 5.729B
Industry Biotechnology
ATAI
Atai Life Sciences N.V.
1.5700
-2.48%
Mkt Cap 304.569M
Industry Biotechnology
MNMD
Mind Medicine (MindMed) Inc.
6.61
+3.61%
Mkt Cap 484.723M
Industry Biotechnology

Statistics: SUPRIYA.NS

View More

Valuation Measures

As of 3/5/2025

  • Market Cap

    49.89B

  • Enterprise Value

    49.07B

  • Trailing P/E

    28.61

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.59

  • Price/Book (mrq)

    5.51

  • Enterprise Value/Revenue

    7.46

  • Enterprise Value/EBITDA

    18.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.02%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.71B

  • Net Income Avi to Common (ttm)

    1.75B

  • Diluted EPS (ttm)

    21.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    843.14M

  • Total Debt/Equity (mrq)

    0.61%

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: SUPRIYA.NS

View More
View More

People Also Watch

AMIORG.NS Ami Organics Limited
2,462.10
+2.38%
 
LATENTVIEW.NS Latent View Analytics Limited
382.90
-0.73%
 
TARSONS.NS Tarsons Products Limited
316.85
+2.89%
 
MEDPLUS.NS MedPlus Health Services Limited
704.30
-2.59%
 
TEGA.NS Tega Industries Limited
1,342.20
+1.89%
 
RATEGAIN.NS RateGain Travel Technologies Limited
505.35
+1.73%
 
CMSINFO.NS CMS Info Systems Limited
449.80
+0.06%
 
CLEAN.NS Clean Science and Technology Limited
1,231.30
-0.96%
 
DATAPATTNS.NS Data Patterns (India) Limited
1,421.10
+0.43%
 
JUBLINGREA.NS Jubilant Ingrevia Limited
658.30
+4.54%
 
MAPMYINDIA.NS C. E. Info Systems Limited
1,664.25
-0.44%
 
SIGACHI.NS Sigachi Industries Limited
40.73
+3.98%
 
PARAS.NS Paras Defence and Space Technologies Limited
898.55
+1.54%
 
LXCHEM.NS Laxmi Organic Industries Limited
182.77
+2.66%
 
GOCOLORS.NS Go Fashion (India) Limited
731.40
+0.24%
 
TATVA.NS Tatva Chintan Pharma Chem Limited
724.75
+3.25%